SCHEMBL215359

SCHEMBL215359

CCC(C)[C@H](N)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15840377 1.00
SCHEMBL215360 1.00
SCHEMBL6314499 1.00
SCHEMBL17867090 1.00
SCHEMBL1114506 1.00
SCHEMBL6314501 1.00
SCHEMBL15106958 1.00
Hydrochloric Acid SCHEMBL738528 0.97 DPP4 (0.47)
Hydrochloric Acid SCHEMBL738527 0.97 DPP4 (0.47)
Hydrochloric Acid SCHEMBL6556151 0.97 DPP4 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2131854-A1 USE OF LHRH ANTAGONISTS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS, IN PARTICULAR OVERACTIVE BLADDER AND/OR DETRUSOR OVERACTIVITY Aeterna Zentaris Gmbh (DE) 2009-12-16 EP claimed
US-20090170783-A1 NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS AETERNA ZENTARIS GMBH (DE) 2009-07-02 US claimed
US-20090075937-A1 LHRH ANTAGONISTS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS AETERNA ZENTARIS GMBH (DE) 2009-03-19 US claimed
WO-2008107446-A1 USE OF LHRH ANTAGONISTS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS, IN PARTICULAR OVERACTIVE BLADDER AND/OR DETRUSOR OVERACTIVITY ÆTERNA ZENTARIS GMBH (DE) 2008-09-12 WO claimed
US-7375127-B2 Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) AE ZENTARIS GMBH (DE) 2008-05-20 US claimed
EP-1869026-A1 NOVEL COMPOUNDS SmithKline Beecham Corporation (US) 2007-12-26 EP claimed
WO-2006105475-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-05 WO claimed
US-7049296-B2 Gamma-secretase inhibitors MERCK SHARP & DOHME LTD. 2006-05-23 US claimed
US-20060014818-A1 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) MUSC FOUNDATION FOR RESEARCH DEVELOPMENT 2006-01-19 US claimed
EP-1263774-B1 GAMMA-SECRETASE INHIBITORS MERCK SHARP & DOHME (GB) 2005-07-20 EP claimed
US-20030055005-A1 Gamma-secretase inhibitors MERCK SHARP & DOHME LTD. (GB) 2003-03-20 US claimed
EP-1263774-A2 GAMMA-SECRETASE INHIBITORS MERCK SHARP &amp; DOHME LTD. (GB) 2002-12-11 EP claimed
WO-2001066564-A2 GAMMA-SECRETASE INHIBITORS MERCK SHARP & DOHME LIMITED (GB) 2001-09-13 WO claimed
US-12606634-B2 Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 DAIICHI SANKYO COMPANY, LIMITED (JP) 2026-04-21 US disclosed
US-12370263-B2 Cyclic dinucleotide derivative based antibody-drug conjugates DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-07-29 US disclosed
US-12350344-B2 Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-07-08 US disclosed
WO-2000037447-A1 9-AMINOACRIDINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2000-06-29 WO disclosed
US-5175338-A Anticoagulants, vasodilation, antilipemic agents TEIJIN LIMITED (JP) 1992-12-29 US disclosed
US-5100782-A Fermentation of Aminonitrile with Actinetobacter Culture SCHERING AKTIENGESELLSCHAFT (DE) 1992-03-31 US disclosed
EP-0386611-A2 Amino acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1990-09-12 EP disclosed